ES2126652T3 - Metodo de citodiagnostico utilizando la alstonina como marcador selectivo y kit de diagnostico conteniendo dicho marcador. - Google Patents

Metodo de citodiagnostico utilizando la alstonina como marcador selectivo y kit de diagnostico conteniendo dicho marcador.

Info

Publication number
ES2126652T3
ES2126652T3 ES93916038T ES93916038T ES2126652T3 ES 2126652 T3 ES2126652 T3 ES 2126652T3 ES 93916038 T ES93916038 T ES 93916038T ES 93916038 T ES93916038 T ES 93916038T ES 2126652 T3 ES2126652 T3 ES 2126652T3
Authority
ES
Spain
Prior art keywords
marker
alstonine
pct
cytodiagnostic
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916038T
Other languages
English (en)
Inventor
Mirko Beljanski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLECULAR INTERNATIONAL RESEAR
Original Assignee
MOLECULAR INTERNATIONAL RESEAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOLECULAR INTERNATIONAL RESEAR filed Critical MOLECULAR INTERNATIONAL RESEAR
Application granted granted Critical
Publication of ES2126652T3 publication Critical patent/ES2126652T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/808—Optical sensing apparatus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

COMPOSICION DE ALSTONINA PARA UTILIZACION COMO MARCADOR SELECTIVO DE CELULAS TUMORALES Y/O ABERRACIONES CROMOSOMICAS, PARA LA DETECCION DE ESTAS MEDIANTE LA MEDICION DE FLUORESCENCIA EN UNOS 375 NM. UTILIZACION PARA LA OBTENCION DE UN REACTIVO DE DIAGNOSTICO, DESTINADO A LA DETECCION DE ENFERMEDADES TUMORALES Y EN CITOGENETICA. APLICACION A LOS DIAGNOSTICOS PRE, DURANTE Y POST
ES93916038T 1992-07-28 1993-07-26 Metodo de citodiagnostico utilizando la alstonina como marcador selectivo y kit de diagnostico conteniendo dicho marcador. Expired - Lifetime ES2126652T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9209283A FR2694193B1 (fr) 1992-07-28 1992-07-28 Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.

Publications (1)

Publication Number Publication Date
ES2126652T3 true ES2126652T3 (es) 1999-04-01

Family

ID=9432327

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916038T Expired - Lifetime ES2126652T3 (es) 1992-07-28 1993-07-26 Metodo de citodiagnostico utilizando la alstonina como marcador selectivo y kit de diagnostico conteniendo dicho marcador.

Country Status (10)

Country Link
US (1) US5567593A (es)
EP (1) EP0605701B1 (es)
JP (1) JPH07503323A (es)
AT (1) ATE172028T1 (es)
BR (1) BR9305588A (es)
CA (1) CA2120002C (es)
DE (1) DE69321454T2 (es)
ES (1) ES2126652T3 (es)
FR (1) FR2694193B1 (es)
WO (1) WO1994002829A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136540A (en) 1994-10-03 2000-10-24 Ikonisys Inc. Automated fluorescence in situ hybridization detection of genetic abnormalities
WO2000025782A1 (en) * 1998-10-29 2000-05-11 Merck & Co., Inc. Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists
WO2001035078A1 (en) * 1999-11-09 2001-05-17 Raytheon Company Method and apparatus for performing cell analysis based on simultaneous multiple marker emissions from neoplasia (casmmen)
US6956695B2 (en) 2001-03-19 2005-10-18 Ikonisys, Inc. System and method for increasing the contrast of an image produced by an epifluorescence microscope
KR20030046063A (ko) * 2001-12-04 2003-06-12 이성문 음식물 찌꺼기와 식물성 찌꺼기를 이용하여 칼슘석회석과(Caco3) 마그네슘(MGO) 장석운모 바이오와재오라이트석 가루를 60매시로 배합하여 숙성시킨칼슘석회질 유기질 비료 제조방법.
WO2006053680A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Ex vivo cancer diagnostic method
WO2006053649A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Method for the detection of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
FR2419725A1 (fr) * 1978-03-13 1979-10-12 Beljanski Mirko Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales
FR2439783A1 (fr) * 1978-03-13 1980-05-23 Beljanski Mirko Procede d'extraction de la serpentine et de l'alstonine
ATE15971T1 (de) * 1981-03-11 1985-10-15 Mirko Beljanski Serpentin, alstonin und sempervirin, medikamente, die die tumor- und krebszellen spezifisch hemmen.
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
AT387860B (de) * 1985-09-16 1989-03-28 Optical Sensing Technology Verfahren und vorrichtung zur tumordiagnose mittels sera
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents

Also Published As

Publication number Publication date
CA2120002A1 (en) 1994-02-03
ATE172028T1 (de) 1998-10-15
EP0605701B1 (fr) 1998-10-07
CA2120002C (en) 2007-12-11
JPH07503323A (ja) 1995-04-06
US5567593A (en) 1996-10-22
BR9305588A (pt) 1995-05-30
FR2694193B1 (fr) 1994-10-28
DE69321454T2 (de) 1999-06-17
WO1994002829A1 (fr) 1994-02-03
FR2694193A1 (fr) 1994-02-04
DE69321454D1 (de) 1998-11-12
EP0605701A1 (fr) 1994-07-13

Similar Documents

Publication Publication Date Title
US4610806A (en) Skin-marking compositions and devices, and their use
DE69104723D1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
LV11430A (lv) 2-Piridilmetilenpoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
ATE226953T1 (de) 3-,8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel und verfahren zu ihrer herstellung
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
DE59404433D1 (de) Meso-tetraphenylporphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
ES2181234T3 (es) Producto de combinacion que asocia un acido nucleico a una sustancia que desorganiza la matriz extracelular para la terapia genica.
AU7635396A (en) Treatment and diagnosis of infections due to helicobacter pylori
ES2126652T3 (es) Metodo de citodiagnostico utilizando la alstonina como marcador selectivo y kit de diagnostico conteniendo dicho marcador.
JPS6422878A (en) Fluorescein derivative and liposome preparation containing the same
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
DE69302829D1 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
EP0353868A3 (en) Phenalenimine fluorescent dyes and their use in analytical compositions, elements and methods
ATE306556T1 (de) Für reduzierende bedingungen empfindliche transfektions-verbindungen, pharmazeutische zusammensezungen die diese enthalten und deren verwendung.
DE69711588D1 (de) Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung
RU94000719A (ru) Алкилбензолы, композиции, содержащие алкилбензолы для визуализации желудочно-кишечного тракта, способ исследования желудочно-кишечного тракта
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
Sonnex et al. Allergic contact dermatitis from chloromethyl heterocyclic intermediate the synthesis of a histamine antagonist
TR200100801T2 (tr) Benzoilguanidin türevleri, imalatlarına yönelik yöntemler, ilaç yapımında kullanımı
Grote et al. Studies on viburnum. III. The uterine sedative action of various fractions
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
AR014969A1 (es) Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen
Wolinsky et al. Effects of the inorganic salts sodium chloride, sodium bicarbonate, and magnesium sulfate upon the growth and motility of Treponema vincentii

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 605701

Country of ref document: ES